Cargando…
Hyperoside alleviates doxorubicin-induced myocardial cells apoptosis by inhibiting the apoptosis signal-regulating kinase 1/p38 pathway
BACKGROUND: Cardiotoxicity is a side effect of the anthracycline broad-spectrum anti-tumor agent, doxorubicin (DOX). Hyperoside, a flavonoid glycoside extracted from many herbs, has anti-apoptotic and anticancer properties. However, its impact on the alleviation of DOX-induced apoptosis in cardiomyo...
Autores principales: | Chen, Lingxia, Qin, Zhi, Ruan, Zhong-bao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200097/ https://www.ncbi.nlm.nih.gov/pubmed/37220525 http://dx.doi.org/10.7717/peerj.15315 |
Ejemplares similares
-
Taxifolin protects rat against myocardial ischemia/reperfusion injury by modulating the mitochondrial apoptosis pathway
por: Tang, Zhenqiu, et al.
Publicado: (2019) -
Naringin protects myocardial cells from doxorubicin-induced apoptosis partially by inhibiting the p38MAPK pathway
por: Jian, Chun-Yan, et al.
Publicado: (2017) -
Construction of a ceRNA network of regulated ferroptosis in doxorubicin-induced myocardial injury
por: Ye, Hongwei, et al.
Publicado: (2023) -
Hyperoside decreases the apoptosis and autophagy rates of osteoblast MC3T3-E1 cells by regulating TNF-like weak inducer of apoptosis and the p38mitogen activated protein kinase pathway
por: Zhang, Qing, et al.
Publicado: (2019) -
Low-dose lipopolysaccharide inhibits spinal cord injury-induced neuronal apoptosis by regulating autophagy through the lncRNA MALAT1/Nrf2 axis
por: Hu, Jianhua, et al.
Publicado: (2023)